Clinical trial
A Phase II Study of Definitive Concurrent Radiation Therapy With Cisplatin and Irinotecan Chemotherapy in Locally Advanced In-operable Non-Small Cell Lung Cancer
NCT02275806 is registered in ClinicalTrials.gov with Leo W. Jenkins Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Definitive Concurrent Radiation Therapy With Cisplatin and Irinotecan Chemotherapy in Locally Advanced In-operable Non-Small Cell Lung Cancer
- Lead sponsor
- Leo W. Jenkins Cancer Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 31, 2014
- Completion date
- September 27, 2017
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung neoplasms, non-small cell lung cancer